Zealand Pharma regains worldwide rights to Amylin analog program from Boehringer Ingelheim

https://www.globenewswire.com/news-release/2020/03/20/2004337/0/en/Zealand-Pharma-regains-worldwide-rights-to-Amylin-analog-program-from-Boehringer-Ingelheim.html

company announcement